Medical Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
Andrew Schoen joined NEA in 2014 and is a Partner focused on enterprise technology investments. He has served as a board director or observer for Aigen, Berkshire Grey (NASDAQ), CCP Games (acquired), Clarifai, Dandelion, Duolingo, Expanse (acquired), IonQ (NYSE), Merge API, and ThreatQ. In addition, he has been involved with NEA’s investments in Beyond Identity, FiscalNote, Onshape (acquired), Pentaho (acquired), PlayVS, Pocket (acquired), Rocket Chat, Theorycraft, Timescale, and Wispr AI. Andrew is also a member of NEA’s Asia investing team and has been involved with NEA’s investments in ByteDance, Xsky and Zuoyebang. In 2018, Andrew was named to the Forbes 30 Under 30 list in Venture Capital. Prior to joining NEA, Andrew was a member of Blackstone’s M&A team in New York. Andrew previously co-founded the digital media company Flicstart (acquired)
